-

Christian Mumenthaler Named to MetLife’s Board of Directors

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that Christian Mumenthaler has been elected to its board of directors, effective May 1, 2025.

Mumenthaler led Swiss Re as Group Chief Executive Officer for eight years until June 2024 and was a member of the Group Executive Committee for more than a decade.

During his more than 25-year career at the Zurich-based global reinsurer, Mumenthaler held numerous senior leadership roles including Group Chief Risk Officer and Head of Life & Health. He also established and headed Swiss Re’s Group Retro and Syndication unit and served as Chief Marketing Officer, Reinsurance, before becoming Chief Executive Officer, Reinsurance, in 2011.

"We are pleased to welcome Christian to MetLife's Board of Directors," said R. Glenn Hubbard, chairman of MetLife, Inc. “His strategic vision and deep expertise in the insurance and reinsurance industries will serve MetLife well in delivering value for all stakeholders.”

MetLife President and CEO Michel Khalaf added: "Christian’s extensive industry knowledge and innovative thinking make him a great addition to the board as we drive our New Frontier strategy forward.”

Mumenthaler holds a doctorate in physics from the Swiss Federal Institute of Technology (ETH) in Zurich. He is well known in the insurance industry and beyond, having served as co-chair of the World Economic Forum Alliance of CEO Climate Leaders; was a board member of the Geneva Association and economiesuisse; and a member of the Pan-European Insurance Forum, the Global Reinsurance Forum, and the steering committee of the Insurance Development Forum.

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

Contacts

For Media:
Dave Franecki
(973) 264-7465
Dave.Franecki@metlife.com

For Investors:
John Hall
(212) 578-7888
John.A.Hall@metlife.com

MetLife, Inc.

NYSE:MET

Release Versions

Contacts

For Media:
Dave Franecki
(973) 264-7465
Dave.Franecki@metlife.com

For Investors:
John Hall
(212) 578-7888
John.A.Hall@metlife.com

More News From MetLife, Inc.

MetLife Study Finds AI Acceleration Is Creating New Concerns in Today’s Workplace

NEW YORK--(BUSINESS WIRE)--As the adoption of artificial intelligence (AI) in the workplace accelerates, MetLife’s 24th Annual U.S. Employee Benefit Trends Study (EBTS) reveals, alongside other findings, a workforce both optimistic about the technology’s efficiency gains and concerned about how technological change is reshaping work, well‑being and long‑term security. MetLife’s 2026 EBTS, released today, shows that AI is already deeply embedded in everyday work: 80% of employers say AI tools ar...

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.002 percent of MetLife shares of common stock outstanding as of February 12, 2026. Potemkin’s offer price of $51.60 per share is approximately 27.09 percent lower than the $70.77 closing price of MetLife common...

MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2026 dividend of $0.31501229 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will s...
Back to Newsroom